Functional deep neural network for high-dimensional data analysis

US12080426B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12080426-B2
Application numberUS-202117217082-A
CountryUS
Kind codeB2
Filing dateMar 30, 2021
Priority dateApr 6, 2020
Publication dateSep 3, 2024
Grant dateSep 3, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Various examples of methods and systems are provided related to functional deep neural networks (FDNNs), which can be used for high dimensional data analysis. In one example, a FDNN can be trained with a training set of omic data to produce a trained FDNN model. The likelihood of a condition can be determined based upon output indications of the FDNN corresponding to the one or more phenotypes, with the output indications based upon analysis of omic data including a multi-level omic profile from an individual by the trained FDNN. The FDNN model can include a series of basis functions as layers to capture complexity between the omic data with disease phenotypes. A treatment or prevention strategy for the individual can be identified based at least in part upon the likelihood of the condition.

First claim

Opening claim text (preview).

Therefore, at least the following is claimed: 1. A method for risk prediction using high-dimensional omic data, comprising: training, by at least one computing device, a functional deep neural network (FDNN) with a training set of omic data to produce a trained FDNN model, the trained FDNN model comprising a series of basis functions as a plurality of layers that capture complexity between the omic data with disease phenotypes after training, the training set of omic data comprising biomarkers applied as inputs to the FDNN and one or more phenotypes, the trained FDNN model configured to provide output indications in a standardized format; obtaining, by the at least one computing device, omic data corresponding to an individual, the omic data comprising a multi-level omic profile from the individual stored in a database; determining, by the at least one computing device, a likelihood of a condition associated with a disease based upon output indications of the FDNN corresponding to the one or more phenotypes, the output indications based upon analysis of the omic data comprising the multi-level omic profile from the individual by the trained FDNN; identifying, by the at least one computing device, a treatment for the individual based at least in part upon the likelihood of the condition; and generating, by the at least one computing device, an indication of the treatment for rendering on a networked computing device, the indication of treatment transmitted to all authorized medical or clinical personnel over a network for real time access via networked computing devices. 2. The method of claim 1 , wherein a first layer of the plurality of layers comprises a univariate function and remaining layers of the plurality of layers comprise a bivariate function. 3. The method of claim 1 , wherein the training set of omic data comprises risk predictors related to the one or more phenotypes, the risk predictors including biomarkers or established risk predictors. 4. The method of claim 3 , wherein the one or more phenotypes comprise disease diagnostic assessments, multiple correlated phenotypes, or high-dimensional phenotypes. 5. The method of claim 4 , wherein the high-dimensional phenotypes comprise biomarkers or neuroimaging data. 6. The method of claim 1 , wherein the plurality of layers of the FDNN are built via functional linear models with functional coefficients as weights in individual layers. 7. The method of claim 6 , wherein the plurality of layers of the FDNN adopts a penalty on a second-order derivative of the basis functions to ensure smoothness of the basis functions. 8. The method of claim 1 , wherein weights and biases in the FDNN are functions, and the FDNN takes an integral of functional coefficients in individual layers. 9. A system for risk prediction using high-dimensional omic data, comprising: at least one computing device comprising processing circuitry including a processor and memory; and a FDNN analysis program that, when executed by the processing circuitry, cause the at least one computing device to: obtain an omic profile of an individual, the omic profile comprising a multi-level omic profile from the individual stored in a database; determining a likelihood of a condition associated with a disease based upon output indications of a functional deep neural network (FDNN) corresponding to one or more phenotypes, the output indications based upon analysis of omic data comprising the multi-level omic profile by the FDNN, where the FDNN was trained with a training set of omic data to produce a trained FDNN model, the trained FDNN model comprising a series of basis functions as a plurality of layers that capture complexity between the omic data with disease phenotypes, the trained FDNN model configured to provide the output indications in a standardized format; providing a treatment identified for the individual based at least in part upon the likelihood of the condition; and generating an indication of the treatment for rendering on a networked computing device or another computing device, the indication of treatment transmitted to all authorized medical or clinical personnel over a network for real time access via networked computing devices. 10. The system of claim 9 , wherein the training set of omic data comprising biomarkers applied as inputs to the FDNN and the one or more phenotypes. 11. The system of claim 10 , wherein the training set of omic data comprises risk predictors related to the one or more phenotypes, the risk predictors including biomarkers or established risk predictors. 12. The system of claim 11 , wherein the one or more phenotypes comprise disease diagnostic assessments, multiple correlated phenotypes, or high- dimensional phenotypes. 13. The system of claim 12 , wherein the high-dimensional phenotypes comprise multi-level omic or neuroimaging data. 14. The system of claim 9 , wherein a first layer of the plurality of layers comprises a univariate function and remaining layers of the plurality of layers comprise a bivariate function. 15. The system of claim 9 , wherein the plurality of layers of the FDNN are built via functional linear models with functional coefficients as weights in individual layers. 16. The system of claim 15 , wherein the plurality of layers of the FDNN adopts a penalty on a second-order derivative of the basis functions to ensure smoothness of the basis functions. 17. The system of claim 9 , wherein weights and biases in the FDNN are functions, and the FDNN takes an integral of functional coefficients in individual layers.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12080426B2 cover?
Various examples of methods and systems are provided related to functional deep neural networks (FDNNs), which can be used for high dimensional data analysis. In one example, a FDNN can be trained with a training set of omic data to produce a trained FDNN model. The likelihood of a condition can be determined based upon output indications of the FDNN corresponding to the one or more phenotypes,…
Who is the assignee on this patent?
Univ Florida, Univ Florida
What technology area does this patent fall under?
Primary CPC classification G16H50/30. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).